The disruption of hematopoietic stem cell transcription and altered Wnt signaling, by way of β-catenin, may interfere with differentiation and contribute to the development of leukemias, implicating SMYD2 as an oncogene [75]. This evidence concerns the gene SMYD2 and leukemia.